Form 4: Spyre Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Cameron Turtle, Chief Executive Officer and a Director of Spyre Therapeutics, Inc., sold 15,000 shares of common stock on September 1, 2026.
Summary
- Open-market sale: disposed of 2,500 Common Stock at $86.36 ($215,900) on September 1, 2026; holds 565,040 after (Direct).
- Open-market sale: disposed of 8,400 Common Stock at $87.15 ($732,060) on September 1, 2026; holds 556,640 after (Direct).
- Open-market sale: disposed of 3,700 Common Stock at $88.06 ($325,822) on September 1, 2026; holds 552,940 after (Direct).
- Open-market sale: disposed of 400 Common Stock at $89.07 ($35,628) on September 1, 2026; holds 552,540 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,309,410 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Cameron Turtle — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market sale | Common Stock | 2,500 | $86 | $215.9K | 565,040 |
| 2026-09-01 | Open-market sale | Common Stock | 8,400 | $87 | $732.1K | 556,640 |
| 2026-09-01 | Open-market sale | Common Stock | 3,700 | $88 | $325.8K | 552,940 |
| 2026-09-01 | Open-market sale | Common Stock | 400 | $89 | $35.6K | 552,540 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market sale (2,500 shares) |
| 2026-09-01 | Open-market sale (8,400 shares) |
| 2026-09-01 | Open-market sale (3,700 shares) |
| 2026-09-01 | Open-market sale (400 shares) |
Keywords
insider transaction, Form 4, SYRE, Spyre Therapeutics, Inc., bearish, Cameron Turtle
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.